Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | RARA | P10276 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8855999 | 0.90 | KDM4E (1.00) | KDM4EMEN1KMT2AHRH3LMNA | |
| SCHEMBL20410871 | 0.89 | KDM4E (0.84) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7176715 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7181592 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7175648 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7174211 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7171435 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7171692 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| Hydrochloric Acid SCHEMBL7173148 | 0.87 | KDM4E (0.93) | KDM4EMEN1KMT2AHRH3LMNA | |
| SCHEMBL20410986 | 0.84 | KDM4E (0.87) | KDM4EMEN1KMT2AHRH3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138348-B2 | Using coordination polymerization catalyst | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138348-B2 | Using coordination polymerization catalyst | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-07-31 | — | — | US | disclosed |
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-07-31 | — | — | US | disclosed |
| WO-2008085655-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE MONO-OXAZOLINE CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | OXER1, OXGR1, OXA1L | KDM4E 2632/4885MEN1 2498/4885RAB9A 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.